1. Market Research
  2. > Healthcare Market Trends
  3. > Harnessing the Power of Patient Support Programmes: pharma, patient and payer perspectives

Harnessing the Power of Patient Support Programmes: pharma, patient and payer perspectives

  • April 2015
  • -
  • Firstword Pharma

Summary

Table of Contents




It all started years ago, with a few patients asking questions on the internet. These days, patient self-education and engagement in treatment and disease management has become a powerful behaviour not just for themselves, but for physicians, pharma and payers alike.

FirstWord explores how pharma is meeting the challenge of patient-centricity. Based on expert interviews, Harnessing the Power of Patient Support Programmes: pharma, patient and payer perspectivesuncovers key trends in patient relationship programs from patient, payer and pharma perspectives, and delves into some of the highly successful and innovative ‘first adopters’ strategies already at work.

The industry has seen a steady rise of patient-centric strategies, such as online patient support programs, inclusion of patient leaders in clinical trial development and the evolution of prescribing relationships. While some in the industry are slow to adopt the new approach, others are embracing the change with open arms. Insightful, wide ranging and compelling, Harnessing the Power of Patient Support Programmes: pharma, patient and payer perspectives offers new insights from experts into what the future holds.







Key Takeaways

Gain insight into the overriding trends in patient support programs and patient-pharma relationships from patient, payer and pharma perspectives
Understand the analysis of successful early adopter projects and programs launched by pharma companies
Get a first look at how companies are developing patient-centric thinking across the organisation, starting with new in house roles, such as ‘chief patient officer’ and ‘patient affairs’
Learn more about the growing trend for patient input in R&D, in particular preclinical and clinical trials
Gain expert knowledge on developing and mapping patient support programs



Answers to Critical Questions

How important and pervasive will patient-centric strategy is becoming?
How can pharma build deep-rooted policies that embrace the empowered patient?
How is the patient-physician relationship evolving, and how does this change the balance of influence in making treatment decisions?
How can pharma companies adapt to the evolving market profile?
Where does patient support sit in the operational structure?
How can companies evaluate, plan, and implement effective patient support programs?
What are payers looking for from patient support programs, and why do some programs fall short of their expectations?


Key Features

Overview of key trends, and of their positive and negative effect on pharma–supported patient programs
Insight into corporate attitudes towards patient-centricity
Case studies of successful programs from UCB, Pfizer and Sanofi
Top tips and take-home messages for implementing successful patient support programs
Insights from 22 experts including nine from the industry, eight payers and five patient opinion leaders

About FirstWord Reports

FirstWord is an innovative industry intelligence leader serving over 240,000 Pharma and MedTech professionals worldwide. FirstWord offers a range of products and services designed to help your company gain a competitive edge by making key business decisions with speed and confidence.

FirstWord Reports deliver timely, need-to-know intelligence about your products, your competitors and your markets. FirstWord Reports provide expert views and intelligence on the challenges facing pharma today in these topic areas: Biosimilars, Market Access, Medical Affairs, Sales & Marketing, Technology, Therapy Areas.
FirstWord Pharma PLUS is a personalised and comprehensive intelligence service delivering up-to-the-minute pharma news, insight, analysis and expert views of importance to your company’s success.

Learn more at www.firstwordgroup.com.


Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

  • $ 59500
  • Industry report
  • January 2017
  • by Venture Planning Group

This unique 68-country survey from VPGMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well ...

2017 World Automated Microbiology Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Volume and Sales Forecasts for 100 Molecular Diagnostic Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

2017 World Automated Microbiology Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Volume and Sales Forecasts for 100 Molecular Diagnostic Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

  • $ 52500
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 75-country survey from VPGMarketResearch.com provides granular data and analysis not available from any other published source. The survey is designed to help current suppliers and potential market ...

2017 Europe Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2017 Europe Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

  • $ 47500
  • Industry report
  • January 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides granular analysis of the Europe diagnostic testing market, including Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, ...


Download Unlimited Documents from Trusted Public Sources

Health Facility Industry in the US

  • April 2017
    15 pages
  • Health Facility  

    Hospital  

  • United States  

View report >

Risky Behaviour Markets in the Netherlands

  • April 2017
    7 pages
  • Risky Behaviour  

  • Netherlands  

View report >

Hospital Industry in the UK

  • April 2017
    183 pages
  • Hospital  

    Intensive Care  

    Health Care Pro...  

  • United Kingdom  

View report >

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.